UPDATE ON UNITED THERAPEUTICS $UTHR

UPDATE ON UNITED THERAPEUTICS $UTHR

This post was just published on ZYX Buy Change Alert.

UTHR has announced that it will continue the FREEDOM-EV study of Orenitram extended-release tablets. This is good news.  However, many analysts were hoping for better news.  A better news would have been if the effectiveness was so good that there would be no need to continue the study as planned.

UTHR remains a takeover target but the probability of a buyout is now lower

What To Do Now

Those in the stock may consider continuing to hold and change stops to mental stops in the zone of $98 to $108.43.  As the dust settles, we may tighten the stops and give further guidance.  Consider not adding at this time.

Those not in the stock may wait for a signal on the Real Time Feed.

You are receiving less than 2% of the content from our paid services …TO RECEIVE REMAINING 98%, TAKE A FREE TRIAL TO PAID SERVICES.

Please click here to take advantage of a FREE  30 day trial.

Check out our enviable performance in both bull and bear markets.

FREE: SUBSCRIBE TO ‘GENERATE WEALTH’ NEWSLETTER

Related Posts

UNITED THERAPEUTICS BUYOUT NOT LIKELY IN THE NEAR TERM AND RISK IS INCREASING, EXIT THE POSITION $UTHR

This post was just published on ZYX Buy Change Alert. United Therapeutics (UTHR) buyout is not likely in the near term and the ...

TAKE ADVANTAGE OF STRENGTH TO TAKE PARTIAL PROFITS ON UNITED THERAPEUTICS, REMAINS A BUYOUT TARGET $UTHR

This post was just published on ZYX Buy Change Alert. UTHR  is long from $129.20.  It is trading at $151.47 as of this ...

A NEW IDEA ON UNITED THERAPEUTICS, BUYOUT RUMORS AT $200 $UTHR $GSK $GILD

This post was just published on ZYX Buy Change Alert. UTHR is a biotech company.  It closed at $127.92.  There are rumors that ...

Follow

Get every new post delivered to your Inbox

Join other followers